14 certified Labor Condition Applications on file with the U.S. Department of Labor, FY2021–FY2025.
Since September 2025, DOL's Project Firewall opens H-1B investigations without waiting for a complaint. These checkpoints come from Nexus Pharmaceuticals Inc.'s own public LCA filings (FY2023–FY2025) — the same records an investigator pulls first.
Next end date: 2027-01-07. Employing an H-1B worker past the LCA end date without a new certified LCA is a strict-liability violation — the replacement LCA must be certified before the I-129 extension is filed.
Frequent amendments usually mean worksite or role changes; each one must be covered by a new LCA before the change takes effect.
Level I is the entry-level prevailing-wage tier and the band DOL's Project Firewall reviews first for misclassification (senior duties filed at an entry-level wage). The national share is 17%.
Median offered wage is 15% above the DOL prevailing wage across 8 recent certified LCAs. Paying at the floor is lawful, but it invites the question of whether the wage level itself is right.
Each worksite needs its own 10-business-day LCA notice and a PAF record of that posting; a move to a new area of intended employment needs a new LCA before the worker starts there.
No additional recruitment or non-displacement attestations apply.
Public DOL disclosure data can lag actual filings by a quarter. Descriptive only — not legal advice.
Yes — Nexus Pharmaceuticals Inc. sponsors H-1B workers, with 14 certified LCAs on file (FY2021–FY2025), including 3 in FY2025. The median certified salary is $100,000 (P25 $90,500, P75 $110,367). 100% of its certified filings meet or exceed the prevailing wage.
Nexus Pharmaceuticals Inc. H-1B sponsorship at a glance, from public U.S. DOL LCA disclosure data (FY2021–FY2025).
Certified LCAs are a prerequisite to H-1B petitions, not visa approvals; one LCA can cover multiple workers. Descriptive only — not legal advice.
The shaded band is the middle half of certified salaries (P25–P75); the bar spans the lowest to highest certified salary.
Levels I–IV are DOL prevailing-wage experience tiers; 79% of filings are senior-level (III–IV).
| Fiscal year | Certified | Denied | Withdrawn | Total |
|---|---|---|---|---|
| FY2021 | 4 | 0 | 0 | 4 |
| FY2022 | 2 | 0 | 0 | 2 |
| FY2023 | 2 | 0 | 1 | 3 |
| FY2024 | 3 | 0 | 0 | 3 |
| FY2025 | 3 | 0 | 0 | 3 |
Case dispositions from the U.S. DOL OFLC disclosure files. Withdrawn are LCAs that were certified and later withdrawn by the employer; they still count toward Total.
| Job title | Salary | Level | Location | Filed | Status |
|---|---|---|---|---|---|
Analytical Scientist III I-200-24345-530918 | $110,490/yr | IV | Lincolnshire, IL | Dec 10, 2024 | Certified |
Formulation Scientist II I-200-24312-461475 | $94,682/yr | III | Lincolnshire, IL | Nov 07, 2024 | Certified |
Lead Scientist, Formulation Development I-200-24281-390715 | $142,000/yr | IV | Lincolnshire, IL | Oct 07, 2024 | Certified |
Formulation Scientist III I-200-24135-994136 | $105,000/yr | IV | Lincolnshire, IL | May 14, 2024 | Certified |
Technical Transfer Associate I-200-24050-729395 | $75,000/yr | II | Lincolnshire, IL | Feb 19, 2024 | Certified |
Analytical Scientist III I-200-24038-701829 | $112,765/yr | IV | Lincolnshire, IL | Feb 07, 2024 | Certified |
Formulation Scientist II I-200-23265-374676 | $92,000/yr | III | Lincolnshire, IL | Sep 22, 2023 | Certified |
Formulation Scientist II I-200-23265-374526 | $92,000/yr | IV | Lincolnshire, IL | Sep 22, 2023 | Withdrawn |
Director, Analytical Research & Development I-200-23138-033832 | $164,800/yr | IV | Lincolnshire, IL | May 18, 2023 | Certified |
Analytical Scientist II I-200-22042-896566 | $100,000/yr | IV | Lincolnshire, IL | Feb 11, 2022 | Certified |
Formulation Scientist I I-200-21328-724999 | $90,000/yr | III | Lincolnshire, IL | Nov 24, 2021 | Certified |
Formulation Scientist II I-200-21237-545754 | $75,000/yr | II | Lincolnshire, IL | Aug 25, 2021 | Certified |
Lead Scientist, Formulation Development I-200-21237-545756 | $110,000/yr | IV | Lincolnshire, IL | Aug 25, 2021 | Certified |
Technical Transfer Associate I-200-21103-219710 | $67,883/yr | II | Lincolnshire, IL | Apr 13, 2021 | Certified |
Manager, Analytical Development & Research I-200-21103-219698 | $110,000/yr | IV | Lincolnshire, IL | Apr 13, 2021 | Certified |
One row per LCA case (its latest version), from U.S. DOL OFLC disclosure data. Salaries are the offered wage, converted to a yearly figure. Certified LCAs are not visa approvals.
Worker positions by LCA filing purpose, summed across FY2021–FY2025 disclosure records.
Most active filing months: Feb and Apr — useful for timing transfer conversations.
Attestations from the employer's own LCA filings (Form ETA-9035), as disclosed by the U.S. DOL.
1 state · 1 city
The same DOL data on this page is what every H-1B sponsor must track for each worker. ElevateStaffing.ai automates it end-to-end:
Get the private PAF / LCA gap check for your own filings — free, one business day — then let ElevateStaffing.ai keep every LCA, PAF, I-9 and I-983 deadline audit-ready.
Get my private gap check →